Otitopic Inc

Pharmaceuticals - Los Angeles, California, United States

Otitopic Inc Employees
Charles PhD

Drug Product Development Program Manager

Contact Charles PhD

Thomas Gibbs

Chief Executive Officer and GBL

Contact Thomas Gibbs

Kambiz Yadidi

Founder of Otitopic Inc.

Contact Kambiz Yadidi

Contact All Otitopic Inc Employees
Otitopic Inc Senior Management
Thomas Gibbs

Chief Executive Officer and GBL

Contact Thomas Gibbs

Kambiz Yadidi

Founder of Otitopic Inc.

Contact Kambiz Yadidi

Contact All Otitopic Inc Employees
Otitopic Inc Details

Our mission is to provide patients with a faster alternative for management of suspected myocardial infarction (MI).OtiTopic, Inc., founded in 2012, is a late-stage clinical pharmaceutical company, with a track record of success in product drug delivery and drug device development. OtiTopic has changed the route of administration of Aspirin and is on track to file an NDA for commercialization and marketing in the US. OtiTopic has developed a dry powder inhalation of aspirin for suspected acute MI patients that enters the bloodstream in less than two minutes. By exploiting the respiratory system as a speedy route of administration, ASPRIHALE® could revolutionize the rapid and complete platelet inhibition and PD effects for suspected acute MI patients, becoming the first non-invasive and heart-specific therapy after FDA approval.To improve prognosis during the pre-hospital period, small differences in the timing of aspirin and fibrinolytic administration were both major determinants to survival in acute MI patients. Once a fibrin fiber-rich thrombus is formed, it is less responsive to antithrombotic therapy and requires an adjunctive mechanical treatment by percutaneous coronary intervention.In the treatment of acute myocardial infarction (MI) the time to treatment is important, suggesting that small differences in time to reducing ischemia make clinically important differences in mortality. Within the first few minutes of symptoms, time to treatment is critical, as there is a striking benefit to quickly achieving reperfusion. Studies have shown "The relationship between reduction of ischemic time and subsequent mortality was demonstrated to be nonlinear and decreases rapidly with time, highlighting the need for a rapid antithrombotic treatment as soon as possible after symptom onset".

Otitopic Inc logo, Otitopic Inc contact details
Website: otitopic.com
Employees: 51 - 200
HQ: ["8774438710","18774438710","4806242505"]
Location: Los Angeles, California, United States
Revenue:
Otitopic Inc Technologies
Email Providers

Outlook

Load Balancers

Apache

CMS

WordPress.org

Other

Mobile Friendly

Hosting

GoDaddy Hosting

View All Technologies Used At Otitopic Inc

Contacting Otitopic Inc: Connect with Executives and Employees

Get in Touch with Otitopic Inc Executives and Employees

Connecting with Otitopic Inc's Executives and Workforce

Accessing Contact Information for Otitopic Inc Executives

Connecting with Otitopic Inc: Reach Out to Their Team

Discover How to Contact Otitopic Inc Executives and Staff

Looking to connect with Otitopic Inc executives or employees?

Seeking to Get in Touch with Otitopic Inc Executives or Staff?

Want to Reach Out to Otitopic Inc Executives or Team Members?

In Search of Contact Details for Otitopic Inc Professionals?

Connecting with Otitopic Inc: Contacting Executives and Staff

Browse companies
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z